A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 166
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : BASDAI
Long Form : Bath AS Disease Activity Index
No. Year Title Co-occurring Abbreviation
2022 Efficacy and safety of Janus kinase inhibitors in patients with ankylosing spondylitis: A systematic review and meta-analysis. AEs, AS, ASAS, BASFI, BASMI, FACIT-F, JAK, MASES, RCTs, SAEs, SF-36 PCS, WPAI
2022 Predicting Probability of Response to Tumor Necrosis Factor Inhibitors for Individual Patients With Ankylosing Spondylitis. AS, BASFI, BMI, CRP, PGA, RCTs, TNFis
2021 "A study protocol for a randomised controlled trial on the efficacy of yoga as an adjuvant therapy for patients with Ankylosing spondylitis amidst COVID-19 pandemic". BASFI, CRP, ESR, PHQ-4
2021 Concomitant Diagnosis of Fibromyalgia and Ankylosing Spondylitis: Relation to Clinical Features and Plasma Pentraxin -3 Level. AS, BASFI, BASMI, BASRI, FM, PTX3, RA, SLE
2021 Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study. AS, CI, TNFi
2021 Evaluating the strength of spinal and proximal girdle muscles in patients with axial spondyloarthritis: Correlation with activity, disability, and functionality. axSpA, HAQ-DI, max, TF, TE
2021 Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis. ADAb, axSpA, MASES, TNF
2021 Prevalence of Subclinical Carotid Atherosclerosis and Vitamin D Deficiency in Egyptian Ankylosing Spondylitis Patients. AS, BASFI, BASMI, CIMT, HDL
2021 The efficacy of manual soft-tissue mobilization in ankylosing spondylitis: A randomized controlled study. AS, BASFI, BASMI, NHP, RMDQ
10  2021 [Relapse of ankylosing spondylitis and its predictors after withdrawal of tumor necrosis factor-alpha inhibitors: a 52-week follow-up study]. ADA, AS, BASMI, CRP, LBP, TNFi
11  2020 Abnormal alpha band power in the dynamic pain connectome is a marker of chronic pain with a neuropathic component. ANP, AS, MEG, NNP, non-NP, NP, SN
12  2020 Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies. AS, ASAS-PR, PROs
13  2020 Functional MR imaging beyond structure and inflammation-radiographic axial spondyloarthritis is associated with proteoglycan depletion of the lumbar spine. AS, BASFI, CR, CRP, GAG, gagCEST, IVDs, MRI
14  2020 Investigation of the effectiveness of aerobic exercise training in individuals with ankylosing spondylitis: Randomized controlled study. AS, BASFI, BASMI
15  2020 Residual Disease Burden in Patients With Axial Spondyloarthritis and Psoriatic Arthritis Despite Low Disease Activity States in a Multiethnic Asian Population. AS, ASDAS-ESR, axSpA, cDAPSA, LDA, MDA, PsA, SD
16  2020 The changing profile of ankylosing spondylitis in the biologic era. AS, NSAID, PSOAS
17  2019 Altered Bacterial-Fungal Interkingdom Networks in the Guts of Ankylosing Spondylitis Patients. AS, ESR, HCs, NSAIDs, SpA
18  2019 Core stability and balance in patients with ankylosing spondylitis. AS, BASFI, BASMI
19  2019 Depression in ankylosing spondylitis and the role of disease-related and contextual factors: a cross-sectional study. AS, HADS-D
20  2019 Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis. AS, ASAS, ROC, TNF
21  2019 Health-Related Quality of Life in Patients with Ankylosing Spondylitis: Relationship with Disease-Related Variables. AS, ASQoL, BASFI, BASMI, BASRI, QoL, SF-36
22  2019 Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis. axSpA
23  2019 Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naive to anti-TNF therapy. AS, BASFI, CRP, ICAM-1, MMP-1
24  2019 Radiologic parameters of ankylosing spondylitis patients treated with anti-TNF-alpha versus nonsteroidal anti-inflammatory drugs and sulfasalazine. anti-TNF-alpha, AS, CRP, ESR, LL, NSAIDs, SSZ
25  2018 Effect of anti-tumor necrosis factor alpha treatment on radiographic progression in patient with ankylosing spondylitis: A systematic review and meta-analysis. anti-TNF, AS, BASFI, CIs, mSASSS, NOS, SMDs
26  2018 High frequency of circulating follicular helper T cells is correlated with B cell subtypes in patients with ankylosing spondylitis. AS, CD, CXCR5, HC, ICOS, IL, Tfh
27  2018 Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study. AS, ASAS, ASDAS, ASQoL, axPsA, BASFI, PsA
28  2018 Prevalence and factors associated with disturbed sleep in outpatients with ankylosing spondylitis. AS, BAS-G, BASFI, HADS, PSQI
29  2018 Smoking quantity determines disease activity and function in Chinese patients with ankylosing spondylitis. AS, BASFI, SMD
30  2018 The efficiency of inspiratory muscle training in patients with ankylosing spondylitis. 6MWT, AS, CG, IMT, TG
31  2017 Cross-cultural adaptation and validation of the Chinese version of the Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S). AS, BASFI, BASMI, HAQ-S, ICC
32  2017 Posttraumatic stress disorder and correlates of disease activity among veterans with ankylosing spondylitis. AS, DMARDs, PTSD
33  2017 Relationship between kinesiophobia and pain, quality of life, functional status, disease activity, mobility, and depression in patients with ankylosing spondylitis AS, BASFI, BASMI, BDI, TSK, VAS
34  2017 Single nucleotide polymorphisms of ABCB1 gene and response to etanercept treatment in patients with ankylosing spondylitis in a Chinese Han population. AS, PCR
35  2017 Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients. AS, ASDAS, BASFI, CRP, ESR, SASDAS, SASDAS
36  2016 Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis. AEs, AS, BASFI, BioTRAC, ESR, HAQ-DI, KM, PtGA
37  2016 Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. AS, axSpA, BASFI, BASMI, nr-axSpA, TNF
38  2016 Dose reduction of recombinant human tumor necrosis factor inhibitors (etanercept) can be effective in ankylosing spondylitis patients with synovitis of the hip in a Chinese population. AS, CRP, ESR
39  2016 Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with ankylosing spondylitis. AS, BAS-G, BASFI, BASMI, CRP, ESR, HADS
40  2016 Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis. AS, BASFI
41  2016 Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters. AS, BASFI, BMI, CRP, DKK1, ESR, mSASSS, TNF, VEGF
42  2016 [Clinical value of Short Form-36 and clinical measures in a prospective cohort study of ankylosing spondylitis patients]. AS, BASFI, BASMI, QoL, SF-36
43  2015 Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis. AS, BAP, BMP-2, CRP, DKK1, ESR, IL-17, MMP-3, OPG, PGE2, RANKL, RT-qPCR, TGT, VEGF
44  2015 Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study. ANCOVA, AS, IL, OPG, sTNFR1
45  2015 CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up. AIx, AS, CRP, ESR, PWV
46  2015 Effectiveness and Drug Survival of TNF Inhibitors in the Treatment of Ankylosing Spondylitis: A Prospective Cohort Study. ADA, AS, ETN, IFX, SSZ, TNF
47  2015 Effects of Aerobic Training in Patients with Ankylosing Spondylitis. 6MWT, AS, BASFI, BASMI, CG, HAQ-S, IG
48  2015 Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care. AS, BASFI, BASMI, MDHAQ, RAPID3
49  2015 Serum Vitamin D and Pyridinoline Cross-Linked Carboxyterminal Telopeptide of Type I Collagen in Patients with Ankylosing Spondylitis. AS, BASFI, BMD, CRP
50  2015 Subclinical Atherosclerosis Is Not Accelerated in Patients with Ankylosing Spondylitis with Low Disease Activity: New Data and Metaanalysis of Published Studies. AS, CV, CVD, IMT, TNF
51  2015 The effect of smoking on clinical and radiographic variables, and acute phase reactants in patients with ankylosing spondylitis. AS, BASFI, mSASSS
52  2014 Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial. AS, BASFI, BASMI, CZP, SpA
53  2014 Effects of Tripterygium glycosides on interleukin-17 and CD4+CD25+CD127low regulatory T-cell expression in the peripheral blood of patients with ankylosing spondylitis. AS, CRP, ESR, IL, TG, TGT
54  2014 Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study. AS, axSpA, BASFI, CG, CV, EG, PWV
55  2014 Efficacy of TNFalpha blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. AS, BASFI, nr-axSpA, RCTs, TNF-alpha
56  2014 Etanercept in the treatment of ankylosing spondylitis: A systematic review and meta-analysis. AS, ASAS 20, BASFI, CI, CRP, DMARD, ETN, MDs, ORs, PBO, RCTs, SSZ
57  2014 Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. AS, CRP, ESR, mSASSS, OASIS
58  2014 Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up. AS, CRP
59  2014 Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis. BASFI, BMD, CRP, ESR, JoAS, PGA
60  2014 Randomized, placebo controlled and double-blind trials of efficacy and safety of adalimumab for treating ankylosing spondylitis: a meta-analysis. AS
61  2014 Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis. anti-TNF, AS, ELISA, PPM1A
62  2014 Serum procalcitonin levels in patients with ankylosing spondylitis. AS, BASFI, BASMI, CRP, ESR
63  2014 Visceral fat reflects disease activity in patients with ankylosing spondylitis. AS, BASFI, BASMI, BMI, VAS
64  2013 Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression. AS, mSASSS, RA
65  2013 Correlations among enthesitis, clinical, radiographic and quality of life parameters in patients with ankylosing spondylitis. AS, BASFI, BASMI, BASRI, ESR, MASES
66  2013 Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial. AS
67  2013 Evaluating the reliability of Persian version of ankylosing spondylitis quality of life (ASQoL) questionnaire and related clinical and demographic parameters in patients with ankylosing spondylitis. AS, ASQoL, BASFI, ICC, QoL
68  2013 Fatigue in spondyloarthritis: a marker of disease activity. A cross-sectional study of 266 patients. SpA, VAS
69  2013 Golimumab for the treatment of ankylosing spondylitis: a NICE single technology appraisal. AEs, AS, CEA, CrIs, ERG, HRQoL, ICER, MS, MTC, NICE, RCTs, RR, STA, TA, TNF-alpha
70  2013 Higher frequency of peripheral blood interleukin 21 positive follicular helper T cells in patients with ankylosing spondylitis. AS, CRP, ESR, HC, ICOS, IL-21, PD-1
71  2013 Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. AS, ASQoL, BASFI, NHP
72  2013 [Effects of comprehensive therapy on serum SPARC levels in ankylosing spondylitis patients accompanied with osteoporosis]. AS, BASFI, BQZD, BSAP, OP, SPARC, TGF-beta1, TNF-alpha
73  2012 Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor alpha inhibitor therapy: results from the Danish nationwide DANBIO registry. AS, BASFI, TNFi, VAS
74  2012 Does vitamin D affect disease severity in patients with ankylosing spondylitis? AS, BASFI, CRP, ESR
75  2012 Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life. AS, BASFI, HC, HMGB1
76  2012 Fatigue and correlation with disease-specific variables, spinal mobility measures, and health-related quality of life in ankylosing spondylitis. AS, BASFI, BMI, CRP, ESR, HRQoL, MAF, SF36, VAS
77  2012 MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. AS, ASAS20, CRP
78  2012 Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial. AS, ETA, nr-axSpA, SI joints
79  2012 Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time. AAU, AS, NCs, PBMCs
80  2012 [The value of ankylosing spondylitis disease activity score in evaluating disease activity of ankylosing spondylitis]. AS, ASDAS-CRP, ASDAS-ESR
81  2011 Clinical correlates of urolithiasis in ankylosing spondylitis. AS, BASFI, BASMI, DM, mSASSS
82  2011 Comparison of radiological indices (SASSS, M-SASSS, BASRI-s, BASRI-t) in patients with ankylosing spondylitis. AS, BASFI, BASMI, BASRI-s, BASRI-t, M-SASSS, SASSS
83  2011 Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE). AS, BASMI, CRP, ETN, FVC, PBO, SPINE
84  2011 Evaluation of a modified arthritis self-efficacy scale for an ankylosing spondylitis UK population. ASES-AS, BASFI, EASi-QoL, HADS, MSRM, NRS, SF-36, UK
85  2011 Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. AS, BASFI, BASRI, FIQ, FM, SF-12
86  2011 Inverse correlation between CD4+ CD25high CD127low/- regulatory T-cells and serum immunoglobulin A in patients with new-onset ankylosing spondylitis. AS, IgA
87  2011 Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis. AS, BASFI, ESR, JIA, MMP-3, SJC, TJC
88  2011 No effect of physiotherapy on the serum levels of adipocytokines in patients with ankylosing spondylitis. AS, BASFI
89  2011 Phenotypic differences between familial versus sporadic ankylosing spondylitis: a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER). AS, REGISPONSER
90  2011 Serum melatonin level in ankylosing spondylitis: is it increased in active disease? AS, BASFI, MLT
91  2011 Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters. AS, BASFI, BASMI, BASRI, CRP, ESR, MRI
92  2011 The relationship between plasma homocysteine level and different treatment modalities in patients with ankylosing spondylitis. AS, BASFI, BASMI, BASRI, CRP, ELISA, IL, TNF-alpha
93  2011 Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population. BASFI, BASFI
94  2011 Validity and reliability of the Turkish version of the Health Assessment Questionnaire for the Spondyloarthropathies. ASQoL, BASFI, BASMI, HAQ-S, HAQ-S, MASES
95  2011 [The efficacy and safety of infliximab in patients with ankylosing spondylitis: results of an open-labeled multicenter study]. AR, AS, BASFI
96  2010 Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial. AS, BASFI, CRP, ESR, NSAID
97  2010 Better short-term clinical response to etanercept in Chinese than Caucasian patients with active ankylosing spondylitis. AS, BASFI, BASGI, CRP, ESR, TNF-alpha
98  2010 Human leucocyte antigen-B27 subtypes in Korean patients with ankylosing spondylitis: higher B*2705 in the patient group. AS, HLA
99  2010 Psychological correlates of self-reported disease activity in ankylosing spondylitis. AS
100  2010 Psychological status and patient-assessed health instruments in ankylosing spondylitis. AS, BASFI, BASMI, SCL-90-R